Review of ayahuasca research finds little controlled evidence for mental health uses

The question

What does the current human evidence say about using ayahuasca to treat mental health and substance use problems, and what are the main gaps?

What they did

Researchers wrote a narrative review of the clinical pharmacology of ayahuasca, a plant-based brew used in traditional ceremonies for centuries that contains several active compounds. They summarized clinical trials and observational studies covering depression, anxiety, post-traumatic stress and substance use disorders. The article also includes the authors’ expert opinion on where the field is heading.

What they found

The authors report that very few findings come from controlled studies, which limits any firm conclusion about how safe or effective ayahuasca is. They note an unresolved debate about how much the subjective psychedelic experience itself contributes to any therapeutic effect, and say this may differ by condition. They also highlight that ayahuasca’s chemical make-up varies a great deal between preparations, making results hard to compare; research on isolated single compounds is now being developed.

The fine print

This is a narrative review, not a systematic review or meta-analysis, so the abstract reports no search strategy, no study counts and no participant numbers. The conclusions reflect the authors’ interpretation and expert opinion. Underlying studies are described as few and largely uncontrolled. This summary is based on the abstract only.

What it means

Interest in ayahuasca for mental health conditions is growing, but the authors conclude the controlled human evidence is still too thin to judge whether it works or how safe it is.

Evidence grade: Very low. This is a narrative expert review with no stated search method, no pooled data and no participant numbers, so it cannot be graded higher.

This summary is based on the study’s published abstract.